The elevation of PSEN gene expression leads to more production of Aβ42, while APOE4 is associated with increased β-amyloid deposition, tau protein hyperphosphorylation and aggregation, accelerated cognitive decline, and exacerbation of AD pathology. This evidence concerns the gene MAPT and Alzheimer disease.